Carregant...
Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapy
PURPOSE OF REVIEW: The autologous antigen-presenting cell immunotherapy, sipuleucel-T, was the first and remains the only US Food and Drug Administration-approved immunotherapy for prostate cancer. In this article, we will summarize recent clinical data on several additional immune-directed strategi...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3444804/ https://ncbi.nlm.nih.gov/pubmed/22410456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e32835205a0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|